Ticker Symbol: VNRX
VolitionRX Ltd
$3.98 - 20-12-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Currency:
USD
Asset
Type: Common Stock
CIK:0000093314
Company Profile
Volition is a multi-national epigenetics company developing simple, easy to use, costeffective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of NucleosomicsTM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: N/A
Website: www.volitionrx.com
CEO: N/A
Tags:
- Health Services
- Medical/Nursing Services
- Finance
- Financial Conglomerates
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.72
Change:
-$0.02
(
-2.85%)
Days Range: $0.71 - $0.76
Beta: 0.59
52wk. High: $2.74
52wk. Low: $0.58
Ytd. Change -71.99%
50 Day Moving Average: $0.90
200 Day Moving Average: $1.35
Shares Outstanding: 78136364
Valuation
Market Cap: 5.7B
PE Ratio: -1.32
EPS (TTM): -0.5519
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A